focus -WSS

focus

author：focus 2025-09-28 01:31:45 - browse：39

Empty biotech lab with no people and green benches and cabinets. -- biotech coverage from STAT — Adobe

Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, according to a report released Tuesday by Jones Lang LaSalle, a commercial real estate services company

Tenant demand, measured by the total amount of new space that companies are looking to lease, dropped from 25.3 million square feet at the end of 2021 to 10.1 million square feet by the second quarter of this year across eight top life science markets: Boston, the Bay Area, San Diego, Raleigh-Durham, Philadelphia, Seattle, Los Angeles, and the Washington, D.C., area.

The real estate numbers presented in JLL’s annual life sciences report are yet another sign that the biotech industry, which outperformed the broader market for years, is in the midst of a slowdown. Lab space is increasingly going unused amid a supply glut, and more companies are looking to sublease space. Real estate observers say there are some signs these trends could turn around in the next year or two, though that is far from certain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Pharma’s losing bet in New Jersey

entertainment

WSS

The world needs the new pandemic treaty

New research sheds light on how often breast cancer is overdiagnosed

Weight loss drugs aren’t covered by Obamacare. That may change

Researchers tackle phage therapy hurdles for wider adoption

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Researchers tackle phage therapy hurdles for wider adoption

Wikipedia

focus

entertainment

23andMe had bad news about my health. I wish a person had delivered it

Clinicians often fail to acknowledge the pain caused by long Covid

How to save PrEP access — and even expand it

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA warns medical device makers about rise in fabricated data

Walensky prepares to leave CDC — and Congress — behind

Pharma’s losing bet in New Jersey

23andMe had bad news about my health. I wish a person had delivered it

The Bio Revolution is changing business and society

entertainment

Abridge raises $150m as clinical notes automation market heats up

Medical students need to learn the potent medicine of empathy

Abridge raises $150m as clinical notes automation market heats up

Unmasking the 'centricity' illusion in clinical trials

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Bird flu makes raw milk dangerous to consume, mouse study finds

hotspot

entertainment

knowledge

focus